Bone Biologics Corp. (BBLG)
0.3948
-0.01
(-2.66%)
USD |
NASDAQ |
Oct 23, 16:00
0.3917
0.00 (0.00%)
After-Hours: 20:00
Bone Biologics Net Income (Quarterly) : -0.7737M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7737M |
| March 31, 2026 | -0.766M |
| December 31, 2025 | -0.6846M |
| September 30, 2025 | -0.6667M |
| June 30, 2025 | -0.7405M |
| March 31, 2025 | -1.017M |
| December 31, 2024 | -1.522M |
| September 30, 2024 | -0.941M |
| June 30, 2024 | -0.7837M |
| March 31, 2024 | -0.866M |
| December 31, 2023 | -1.550M |
| September 30, 2023 | -1.920M |
| June 30, 2023 | -1.769M |
| March 31, 2023 | -3.710M |
| December 31, 2022 | 0.8935M |
| September 30, 2022 | -1.219M |
| June 30, 2022 | -0.4693M |
| March 31, 2022 | -0.6895M |
| December 31, 2021 | -0.1777M |
| September 30, 2021 | -0.5093M |
| June 30, 2021 | -0.4919M |
| March 31, 2021 | -0.4317M |
| December 31, 2020 | -0.4537M |
| September 30, 2020 | -0.394M |
| June 30, 2020 | -0.38M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.5969M |
| December 31, 2019 | -0.5311M |
| September 30, 2019 | -0.5614M |
| June 30, 2019 | -0.9256M |
| March 31, 2019 | -1.407M |
| December 31, 2018 | -1.471M |
| September 30, 2018 | -0.2417M |
| June 30, 2018 | -1.263M |
| March 31, 2018 | -1.455M |
| December 31, 2017 | -2.315M |
| September 30, 2017 | -2.376M |
| June 30, 2017 | 1.016M |
| March 31, 2017 | -2.922M |
| December 31, 2016 | -9.728M |
| September 30, 2016 | -4.372M |
| June 30, 2016 | -4.800M |
| March 31, 2016 | -6.978M |
| December 31, 2015 | -7.981M |
| September 30, 2015 | -3.363M |
| June 30, 2015 | -0.8908M |
| March 31, 2015 | -1.642M |
| December 31, 2014 | -1.060M |
| September 30, 2014 | -2.613M |
| June 30, 2014 | -0.4642M |
| January 31, 2014 | -0.002M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.7737M |
| EPS Diluted (Quarterly) | -0.4306 |
| Enterprise Value | -3.317M |
| Earnings Yield | -407.8% |
| Normalized Earnings Yield | -408.00 |